172 related articles for article (PubMed ID: 30305606)
41. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
[TBL] [Abstract][Full Text] [Related]
42. Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP.
Ueda J; Tachibana M; Ikura T; Shinkai Y
J Biol Chem; 2006 Jul; 281(29):20120-8. PubMed ID: 16702210
[TBL] [Abstract][Full Text] [Related]
43. Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis.
Inagawa M; Nakajima K; Makino T; Ogawa S; Kojima M; Ito S; Ikenishi A; Hayashi T; Schwartz RJ; Nakamura K; Obayashi T; Tachibana M; Shinkai Y; Maeda K; Miyagawa-Tomita S; Takeuchi T
Mech Dev; 2013; 130(11-12):519-31. PubMed ID: 23892084
[TBL] [Abstract][Full Text] [Related]
44. ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia.
Gallagher KM; Roderick JE; Tan SH; Tan TK; Murphy L; Yu J; Li R; O'Connor KW; Zhu J; Green MR; Sanda T; Kelliher MA
Blood Adv; 2020 Jul; 4(13):3154-3168. PubMed ID: 32658986
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells.
Wojtala M; Macierzyńska-Piotrowska E; Rybaczek D; Pirola L; Balcerczyk A
Pharmacol Res; 2018 Feb; 128():252-263. PubMed ID: 29113759
[TBL] [Abstract][Full Text] [Related]
46. G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta.
Pless O; Kowenz-Leutz E; Knoblich M; Lausen J; Beyermann M; Walsh MJ; Leutz A
J Biol Chem; 2008 Sep; 283(39):26357-63. PubMed ID: 18647749
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
Irifuku T; Doi S; Sasaki K; Doi T; Nakashima A; Ueno T; Yamada K; Arihiro K; Kohno N; Masaki T
Kidney Int; 2016 Jan; 89(1):147-57. PubMed ID: 26444031
[TBL] [Abstract][Full Text] [Related]
48. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
[TBL] [Abstract][Full Text] [Related]
49. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing.
Mozzetta C; Pontis J; Fritsch L; Robin P; Portoso M; Proux C; Margueron R; Ait-Si-Ali S
Mol Cell; 2014 Jan; 53(2):277-89. PubMed ID: 24389103
[TBL] [Abstract][Full Text] [Related]
50. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells.
Chen H; Yan Y; Davidson TL; Shinkai Y; Costa M
Cancer Res; 2006 Sep; 66(18):9009-16. PubMed ID: 16982742
[TBL] [Abstract][Full Text] [Related]
51. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
52. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
[TBL] [Abstract][Full Text] [Related]
54. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
55. Cyclin D1 integrates G9a-mediated histone methylation.
Li Z; Jiao X; Di Sante G; Ertel A; Casimiro MC; Wang M; Katiyar S; Ju X; Klopfenstein DV; Tozeren A; Dampier W; Chepelev I; Jeltsch A; Pestell RG
Oncogene; 2019 May; 38(22):4232-4249. PubMed ID: 30718920
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).
Lenstra DC; Al Temimi AHK; Mecinović J
Bioorg Med Chem Lett; 2018 Apr; 28(7):1234-1238. PubMed ID: 29519735
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.
Guo AS; Huang YQ; Ma XD; Lin RS
Mol Med Rep; 2016 Nov; 14(5):4613-4621. PubMed ID: 27748874
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts.
Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936
[TBL] [Abstract][Full Text] [Related]
59. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
60. Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia.
Rainer J; Lelong J; Bindreither D; Mantinger C; Ploner C; Geley S; Kofler R
Mol Endocrinol; 2012 Jan; 26(1):178-93. PubMed ID: 22074950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
